Sherry, Norelle <br/><br/>
Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications.  [electronic resource] 

 -  Expert review of anti-infective therapy  04 2018 
 - 289-306 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8336 
<br/><br/><label>Standard No.: </label>10.1080/14787210.2018.1453807  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Bacterial Agents--pharmacology<br/>Azabicyclo Compounds--pharmacology<br/>Ceftazidime--pharmacology<br/>Colistin--pharmacology<br/>Drug Combinations<br/>Drug Resistance, Multiple, Bacterial<br/>Fosfomycin--pharmacology<br/>Gram-Negative Bacteria--drug effects<br/>Gram-Negative Bacterial Infections--drug therapy<br/>Humans<br/>Microbial Sensitivity Tests